Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis

Authors

Basile Njei (ORCID: https://orcid.org/0000-0003-0714-4368)
Solomon Gyabaah (ORCID: https://orcid.org/0000-0002-5941-9733)
Sarpong Boateng (ORCID: https://orcid.org/0000-0003-0199-0424)
Yussif Issaka (ORCID: https://orcid.org/0009-0007-2538-6172)
Edgar Luna Landa
Guy Nguefang
Joel Gabin Konlack
Elvis Eze

Institutions

Texas Tech University (US)
New York City Health and Hospitals Corporation (US)
Brooklyn Hospital Center (US)
Yale New Haven Hospital (US)
Komfo Anokye Teaching Hospital (GH)
Bridgeport Hospital (US)
Yale University (US)
Ohio University (US)
University of Bangui (CF)
Yale New Haven Health System (US)
Texas Tech University Health Sciences Center (US)
University of Cumbria (GB)

Publication Details

Journal: Orphanet Journal of Rare Diseases
Published: 2026-03-28
DOI: https://doi.org/10.1186/s13023-026-04322-5
Primary Topic: Hemoglobinopathies and Related Disorders
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis

Basile Njei, Solomon Gyabaah, Sarpong Boateng, Yussif Issaka et al.

Mar 28, 2026

Orphanet Journal of Rare Diseases

Hemoglobinopathies and Related Disorders

article

Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis

Basile Njei, Solomon Gyabaah, Sarpong Boateng, Yussif Issaka, Edgar Luna Landa, Guy Nguefang, Joel Gabin Konlack, Elvis Eze

March 28, 2026article en

Abstract

No abstract available for this paper.

Orphanet Journal of Rare Diseases

Texas Tech University (US), New York City Health and Hospitals Corporation (US), Brooklyn Hospital Center (US), Yale New Haven Hospital (US), Komfo Anokye Teaching Hospital (GH), Bridgeport Hospital (US), Yale University (US), Ohio University (US), University of Bangui (CF), Yale New Haven Health System (US), Texas Tech University Health Sciences Center (US), University of Cumbria (GB)

Good health and well-being

Openalex Percentile: Top 3%

Hemoglobinopathies and Related Disorders

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis — Basile Njei, Solomon Gyabaah, et al. · Orphanet Journal of Rare Diseases (2026) | TGRS Research Map | TGRS